Dunlop A. Sinclair (CIK 0001721108)

Latest company ownership

Shares held
158,393
Last filed at
Oct 2, 2025
Confidence Score
39.0
2025Q4
Confidence Score History
2019Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 24, 2025 Oct 15, 2025 Apellis Pharmaceuticals, Inc. Director Sell 12.5 -39,716 -20.54% ✓ $737.5K
Sep 30, 2025 Oct 2, 2025 Apellis Pharmaceuticals, Inc. Director Sell 17.5 -34,929 -15.63% ✓ $702.1K
Sep 19, 2025 Sep 19, 2025 Apellis Pharmaceuticals, Inc. Director Sell 22.5 -34,929 -13.52% ✓ $713.6K
Sep 16, 2024 Sep 17, 2024 Apellis Pharmaceuticals, Inc. Director Sell 20.0 -37,000 -13.00% ✓ $1.3M
Jun 21, 2024 Jun 21, 2024 Apellis Pharmaceuticals, Inc. Director Sell 20.0 -37,000 -10.90% ✓ $1.5M
Mar 19, 2024 Mar 20, 2024 Apellis Pharmaceuticals, Inc. Director Sell 17.5 -18,681 -5.24% ✗ $1.1M
Dec 1, 2023 Dec 5, 2023 Apellis Pharmaceuticals, Inc. Director Sell 17.5 -24,000 -6.47% ✗ $1.5M
Nov 17, 2023 Nov 21, 2023 Apellis Pharmaceuticals, Inc. Director Sell 20.0 -8,894 -2.34% ✗ $444.6K
Oct 17, 2023 Nov 21, 2023 Apellis Pharmaceuticals, Inc. Director Sell 17.5 -24,000 -5.94% ✗ $1.2M
Apr 3, 2023 Apr 5, 2023 Apellis Pharmaceuticals, Inc. Director Sell 53.8 -500 -0.12% ✓ $37K
Mar 1, 2023 Mar 2, 2023 Apellis Pharmaceuticals, Inc. Director Sell 53.8 -500 -0.12% ✓ $32.7K
Feb 1, 2023 Feb 2, 2023 Apellis Pharmaceuticals, Inc. Director Sell 53.8 -500 -0.12% ✓ $26.3K
Jan 3, 2023 Jan 5, 2023 Apellis Pharmaceuticals, Inc. Director Sell 53.8 -500 -0.12% ✓ $25.4K
Dec 1, 2022 Dec 2, 2022 Apellis Pharmaceuticals, Inc. Director Sell 53.8 -500 -0.12% ✓ $25K
Nov 1, 2022 Nov 3, 2022 Apellis Pharmaceuticals, Inc. Director Sell 53.8 -500 -0.12% ✓ $30.4K
Sep 8, 2022 Sep 8, 2022 Apellis Pharmaceuticals, Inc. Director Sell 20.0 -15,000 -3.59% ✗ $975K
Aug 11, 2022 Aug 12, 2022 Apellis Pharmaceuticals, Inc. Director Sell 17.5 -30,000 -7.17% ✗ $2M
Jun 27, 2022 Jun 29, 2022 Apellis Pharmaceuticals, Inc. Director Sell 40.0 -1,341 -0.47% ✗ $62.7K
Jun 23, 2022 Jun 24, 2022 Apellis Pharmaceuticals, Inc. Director Sell 20.0 -15,000 -4.99% ✗ $675K
May 18, 2021 May 20, 2021 Apellis Pharmaceuticals, Inc. Director Sell 16.3 -162,873 -9.38% ✗ $8.6M
Dec 14, 2020 Dec 15, 2020 Apellis Pharmaceuticals, Inc. Director Sell 17.5 -25,000 -12.52% ✗ $1.4M
Dec 4, 2020 Dec 7, 2020 Apellis Pharmaceuticals, Inc. Director Sell 17.5 -25,000 -11.12% ✗ $1.3M
Dec 18, 2019 Dec 20, 2019 Apellis Pharmaceuticals, Inc. Director Sell 17.5 -136,000 -10.41% ✗ $4M